13 Dec 2023ALS-6000-101 Phase 1a Three-Weekly Dose Escalation Safety Study DataInvestors | Therapeutics
05 Oct 2023Avacta to present promising new data from Affimer® and pre|CISIONTM platform assets at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer TherapeuticsInvestors | Therapeutics